NA Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030

TABLE OF CONTENT

1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 PRODUCT TYPE LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 Cognate Lifesciences MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 68
2.11 VENDOR SHARE ANALYSIS 69
2.12 SECONDARY SOURCES 70
2.13 ASSUMPTIONS 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 73
4.1 PORTER’S FIVE FORCES 74
4.2 PESTEL ANALYSIS 75
4.3 MICRO AND MACRO ECONOMIC FACTORS 76
4.4 PENETRATION AND GROWTH PROSPECT MAPPING 76
4.5 KEY PRICING STRATEGIES 77
5 REGULATORY COMPLIANCE 78
5.1 REGULATORY AUTHORITIES 78
5.2 REGULATORY CLASSIFICATIONS 78
5.3 REGULATORY SUBMISSIONS 78
5.4 INTERNATIONAL HARMONIZATION 79
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO 80
5.6 REGULATORY CHALLENGES AND STRATEGY 80
5.6.1 REGULATORY SCENARIO IN THE U.S. 80
6 MARKET OVERVIEW 81
6.1 DRIVERS 83
6.1.1 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS 83
6.1.2 INCREASING APPLICATION OF DIGITAL PCR 83
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE 84
6.2 RESTRAINTS 84
6.2.1 LIMITATIONS IN ANALYZING NOVEL COMPLEX DEVICES 84
6.2.2 HIGH COST OF DIGITAL PCR DEVICES 85
6.3 OPPORTUNITIES 85
6.3.1 RISING FREQUENCY OF INFECTIOUS DISEASES 85
6.3.2 RISING PRODUCT INNOVATIONS THROUGH R&D ACTIVITIES 85
6.4 CHALLENGES 86
6.4.1 STRINGENT REGULATIONS AND LEGAL CHALLENGES FOR DIGITAL PCR 86
6.4.2 LACK OF SKILLED PROFESSIONALS PERFORMING DIGITAL PCR 86
7 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY PRODUCT TYPE 88
7.1 OVERVIEW 89
7.2 DIGITAL PCR INSTRUMENTS 92
7.2.1 BY MODALITY 92
7.2.1.1 STANDLONE 92
7.2.1.2 PORTABLE 92
7.2.2 BY METHOD 92
7.2.2.1 PLATE-BASED DPCR 93
7.2.2.2 CHIP BASED DPCR 93
7.2.2.3 MICROFLUIDIC CHAMBER BASED DPCR 93
7.2.2.4 OTHERS 93
7.3 CONSUMABLES AND REAGENTS 93
7.3.1 REAGENTS 93
7.3.1.1 DNA OR PCR TEMPLATES 94
7.3.1.2 DNA POLYMERASE ENZYME 94
7.3.1.3 PRIMERS 94
7.3.1.4 DEXOYNUCLEOTIDE TRIPHOSPHATES (DNTPS) 94
7.3.1.5 PCR BUFFERS 94
7.3.1.6 PCR KIT 94
7.3.2 CONSUMABLES 95
7.3.2.1 PLATES 95
7.3.2.2 TUBES & CAPS 95
7.3.2.3 PLASTIC ACCESSORIES 95
7.3.2.4 PLATE SEALS 95
7.3.2.5 CARTRIDGES 96
7.3.2.6 OTHERS 96
7.4 SOFTWARE AND SERVICES 96
8 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY TECHNOLOGY 97
8.1 OVERVIEW 98
8.2 DROPLET DIGITAL PCR 101
8.2.1 CLINICAL 101
8.2.2 LIFE SCIENCE & RESEARCH 101
8.2.3 OTHERS 101
8.3 BEAMING DIGITAL PCR 102
8.3.1 CLINICAL 102
8.3.2 LIFE SCIENCE & RESEARCH 102
8.3.3 OTHERS 102
9 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY APPLICATION 103
9.1 OVERVIEW 104
9.2 CLINICAL 107
9.2.1 ONCOLOGY TESTING 107
9.2.2 INFECTIOUS DISEASE TESTING 107
9.2.2.1 HIV 108
9.2.2.2 HCV 108
9.2.2.3 HEPATITIS B VIRUS 108
9.2.2.4 HUMAN PAPILLOMAVIRUS 108
9.2.2.5 OTHERS 108
9.2.3 BLOOD SCREENING 108
9.2.4 TRANSPLANT DIAGNOSTICS 108
9.3 LIFE SCIENCE & RESEARCH 109
9.3.1 MICROBIOLOGY 109
9.3.2 MOLECULAR AND CELL BIOLOGY 109
9.3.3 OTHERS 109
9.4 OTHERS 109
10 NORTH AMERICA DIGITAL POLYMERASE CHAIN (PCR) REACTION MARKET, BY END USER 110
10.1 OVERVIEW 111
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 114
10.3 HOSPITALS AND CLINICS 114
10.3.1 PRIVATE 114
10.3.1.1 TIER 1 114
10.3.1.2 TIER 2 115
10.3.1.3 TIER 3 115
10.3.2 PUBLIC 115
10.3.2.1 TIER 1 115
10.3.2.2 TIER 2 115
10.3.2.3 TIER 3 115
10.4 DIAGNOSTIC LABORATORIES 116
10.5 ACADEMIC AND RESEARCH ORGANIZATIONS 116
10.6 REFERENCE LABORATORIES 116
10.7 OTHERS 116
11 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL 117
11.1 OVERVIEW 118
11.2 DIRECT TENDER 121
11.3 RETAIL SALES 121
11.4 OTHERS 121
12 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REGION 122
12.1 NORTH AMERICA 123
13 NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, COMPANY LANDSCAPE 144
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 144
14 SWOT ANALYSIS 145 
15 COMPANY PROFILE 146
15.1 F. HOFFMANN- LA ROCHE LTD 146
15.1.1 COMPANY SNAPSHOT 146
15.1.2 REVENUE ANALYSIS 146
15.1.3 COMPANY SHARE ANALYSIS 147
15.1.4 PRODUCT PORTFOLIO 147
15.1.5 RECENT DEVELOPMENT 147
15.2 BIO-RAD LABORATORIES, INC 148
15.2.1 COMPANY SNAPSHOT 148
15.2.2 REVENUE ANALYSIS 148
15.2.3 COMPANY SHARE ANALYSIS 149
15.2.4 PRODUCT PORTFOLIO 149
15.2.5 RECENT DEVELOPMENTS 149
15.3 MERCK KGAA 151
15.3.1 COMPANY SNAPSHOT 151
15.3.2 REVENUE ANALYSIS 151
15.3.3 COMPANY SHARE ANALYSIS 152
15.3.4 PRODUCT PORTFOLIO 152
15.3.5 RECENT DEVELOPMENT 152
15.4 THERMO FISHER SCIENTIFIC 153
15.4.1 COMPANY SNAPSHOT 153
15.4.2 REVENUE ANALYSIS 153
15.4.3 COMPANY SHARE ANALYSIS 154
15.4.4 PRODUCT PORTFOLIO 154
15.4.5 RECENT DEVELOPMENTS 154
15.5 QIAGEN 156
15.5.1 COMPANY SNAPSHOT 156
15.5.2 REVENUE ANALYSIS 156
15.5.3 COMPANY SHARE ANALYSIS 157
15.5.4 PRODUCT PORTFOLIO 157
15.5.5 RECENT DEVELOPMENT 157
15.6 ACCUMAX 159
15.6.1 COMPANY SNAPSHOT 159
15.6.2 PRODUCT PORTFOLIO 159
15.6.3 RECENT DEVELOPMENT 159
15.7 EPPENDORF SE 160
15.7.1 COMPANY SNAPSHOT 160
15.7.2 PRODUCT PORTFOLIO 160
15.7.3 RECENT DEVELOPMENT 160
15.8 JN MEDSYS 161
15.8.1 COMPANY SNAPSHOT 161
15.8.2 PRODUCT PORTFOLIO 161
15.8.3 RECENT DEVELOPMENT 162
15.9 PRECIGENOME LLC 163
15.9.1 COMPANY SNAPSHOT 163
15.9.2 PRODUCT PORTFOLIO 163
15.9.3 RECENT DEVELOPMENT 163
15.10 RAINSURE SCIENTIFIC 164
15.10.1 COMPANY SNAPSHOT 164
15.10.2 PRODUCT PORTFOLIO 164
15.10.3 RECENT DEVELOPMENT 164
15.11 STANDARD BIOTOOLS 165
15.11.1 COMPANY SNAPSHOT 165
15.11.2 REVENUE ANALYSIS 165
15.11.3 PRODUCT PORTFOLIO 166
15.11.4 RECENT DEVELOPMENT 166
15.12 STILLA 167
15.12.1 COMPANY SNAPSHOT 167
15.12.2 PRODUCT PORTFOLIO 167
15.12.3 RECENT DEVELOPMENT 167
15.13 SYSMEX CORPORATION 168
15.13.1 COMPANY SNAPSHOT 168
15.13.2 REVENUE ANALYSIS 168
15.13.3 PRODUCT PORTFOLIO 169
15.13.4 RECENT DEVELOPMENT 169
15.14 VSI ELECTRONICS PVT. LTD 170
15.14.1 COMPANY SNAPSHOT 170
15.14.2 PRODUCT PORTFOLIO 170
15.14.3 RECENT DEVELOPMENT 170
16 QUESTIONNAIRE 171
17 RELATED REPORTS 174